Presbyopia-mitigating IOL designs are important advances in refractive cataract surgery. It has been a concern for many surgeons and patients if a presbyopia mitigating IOLs should be used in patients with glaucoma. In this video, Dr. Daniel Terveen, MD, reviews the visual and patient reported outcomes from a prospective, controlled, open-label, interventional study of AcrySof IQ Vivity non-diffractive EDOF in cataract patients with mild controlled glaucoma. 

Daniel Terveen, MD